Abstract
Human experimentations refer to medical investigations with humans involved as experimental subjects. These trials are prospective researches aimed at answering specific questions about biomedical interventions, generating safety and efficacy data on drugs and treatments, innovative devices or novel vaccines, as well as new ways of using known interventions.
After a brief introduction of human experimentations, this section presents the main related issues in Law and Economics, i.e., the risk sharing between society and pharmaceutical industry.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Criscuolo P (2005) On the road again: researcher mobility inside the R&D network. Res Policy 34:1350–1365
Ippoliti R (2013) The market of human experimentation. Eur J Law Econ 35(1):61–85
LEEM report (2008) L’industrie du médicament en France, réalités économiques Les Entreprises du Médicament (LEEM), 2008 edn, Paris.
The Association of the British Pharmaceutical Industry (1994) Clinical trial compensation guidelines. ABPI, London
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this entry
Cite this entry
Ippoliti, R. (2019). Human Experimentation. In: Marciano, A., Ramello, G.B. (eds) Encyclopedia of Law and Economics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7753-2_237
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7753-2_237
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7752-5
Online ISBN: 978-1-4614-7753-2
eBook Packages: Economics and FinanceReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences